Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Varian Semiconductor Equipment Associates -- VSEA -- Ignore unavailable to you. Want to Upgrade?

To: Proud_Infidel who wrote (1513)	3/12/2002 12:22:46 PM
From: dantecristo	Respond to of 1929

A momentous error! "No court, including this court, has ever found any of the postings or website pages to be defamatory as a matter of law." geocities.com

To: Proud_Infidel who wrote (1513)	4/17/2002 5:22:56 PM
From: Proud_Infidel	Read Replies (2) \| Respond to of 1929

Varian Semiconductor Retains Its Number One Market Share Position Report Shows VSEA as the Leading Ion Implant Tool Supplier GLOUCESTER, Mass.--(BUSINESS WIRE)--April 17, 2002--Varian Semiconductor Equipment Associates, Inc. (NASDAQ: VSEA - news), today announced that the company has again achieved the number one ion implant tool supplier position, according to a report just released by Dataquest. Varian Semiconductor led the ion implant industry with 36 percent overall market share on a unit basis, and 35 percent overall market share on a dollar basis in calendar 2001. ``Varian Semiconductor has continued to benefit from the single-wafer advantages of its VIISta platform, achieving the leadership status in market share of worldwide ion implant tool sales,'' remarked Richard A. Aurelio, Varian Semiconductor's chairman and chief executive officer. ``Clearly, our market share position reflects our customers' acceptance of the throughput advantages of single-wafer processing.'' Dean Freeman, principal analyst for Gartner Dataquest, said, ``Varian Semiconductor retained the leadership position in unit and dollar market share despite the downturn conditions in the semiconductor industry.'' Varian Semiconductor realized the leadership position in market share through the increased sales of its VIISta tools, which have higher selling prices reflecting the greater capability they deliver to customers for 300mm and 200mm applications. ``Our focus is developing innovative products to maximize our customers' return on investment,'' said Ernest Godshalk, Varian Semiconductor's president and chief operating officer. ``The Dataquest report clearly demonstrates that our leadership in technology and customer satisfaction results in the number one market share position.'' About Varian Semiconductor Varian Semiconductor Equipment Associates is the leading producer of ion implantation equipment used in the manufacture of semiconductors. The company is headquartered in Gloucester, Massachusetts, and operates worldwide. Varian Semiconductor maintains a web site at www.vsea.com. The information contained in our web site is not incorporated by reference into this release, and our web site address is included in this release as an inactive textual reference only. Note: This press release contains forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. For this purpose, the statements concerning the company's operating outlook, market share and technology leadership are forward-looking statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These include, among others, volatility in the semiconductor equipment industry; economic conditions in general and as they affect the company's customers; significant fluctuations in the company's quarterly operating results; the impact of rapid technological change and the company's dependence on the development and introduction of new products; the company's concentration on ion implantation systems and related products; concentration in the company's customer base and lengthy sales cycles; the highly competitive market in which the company competes; risks of international sales; foreign currency risks; general economic conditions; and other factors identified in the company's Annual Report on Form 10-K, and the most recent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. The company cannot guarantee any future results, levels of activity, performance or achievement. The company undertakes no obligation to update any of the forward-looking statements after the date of this press release.